[Therapy of lipodystrophy: no clear answers to clinical questions].
Volkert
R
R
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008060:Lipodystrophy / Q000150:complications / Q000209:etiology / Q000628:therapy*; D008659:Metabolic Diseases / Q000139:chemically induced / Q000150:complications; D012307:Risk Factors; D013959:Thyroid Diseases / Q000139:chemically induced
D019380:Anti-HIV Agents